Abstract:Hippo pathway is an evolutionarily conservative key pathway that regulates organ size and tissue regeneration by regulating cell proliferation, differentiation and apoptosis. Yes-associated protein 1 (YAP)/ WW domain-containing transcription regulator 1 (TAZ) serves as a pivotal transcription factor within the Hippo signaling pathway, which undergoes negative regulation by the Hippo pathway. The expression of YAP/TAZ affects various biological processes, including differentiation of osteoblasts (OB) and osteoclasts (OC), cartilage homeostasis, skeletal muscle development, regeneration and quality maintenance. At the same time, the dysregulation of the Hippo pathway can concurrently contribute to the development of various musculoskeletal disorders, including bone tumors, osteoporosis (OP), osteoarthritis (OA), intervertebral disc degeneration (IDD), muscular dystrophy, and rhabdomyosarcoma (RMS). Therefore, targeting the Hippo pathway has emerged as a promising therapeutic strategy for the treatment of musculoskeletal disorders. The focus of this review is to elucidate the mechanisms by which the Hippo pathway maintains homeostasis in bone, cartilage, and skeletal muscle, while also providing a comprehensive summary of the pivotal role played by core components of this pathway in musculoskeletal diseases. The efficacy and feasibility of Hippo pathway-related drugs for targeted therapy of musculoskeletal diseases are also discussed in our study. These endeavors offer novel insights into the application of Hippo signaling in musculoskeletal disorders, providing effective therapeutic targets and potential drug candidates for treating such conditions.

Hippo/YAP1 promotes osteoporotic mice bone defect repair via the activating of Wnt signaling pathway

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling

YAP1 is Essential for Osteoclastogenesis Through a TEADs-dependent Mechanism

The Hippo signalling pathway in bone homeostasis: Under the regulation of mechanics and aging

Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders

Molecular mechanisms of the mammalian Hippo signaling pathway.

Up-regulation of FOXD1 by YAP Alleviates Senescence and Osteoarthritis.

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

Hippo-YAP/TAZ signaling in osteogenesis and macrophage polarization: Therapeutic implications in bone defect repair

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

The Emerging Role of Hippo Signaling Pathway in Regulating Osteoclast Formation

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

The Effect of ROS-YAP Crosstalk on Osteoimmune Response Orchestrating Osteogenesis.

YAP1 Inhibits the Induction of TNF‐α‐stimulated Bone‐resorbing Mediators by Suppressing the NF‐κB Signaling Pathway in MC3T3‐E1 Cells

YAP/TEAD1 and Β‐catenin/lef1 Synergistically Induce Estrogen Receptor Α to Promote Osteogenic Differentiation of Bone Marrow Stromal Cells

Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development